Combining fulvestrant (Faslodex (TM)) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial
Tools
Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author]
(2008)
Combining fulvestrant (Faslodex (TM)) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial.
CLINICAL ONCOLOGY, 20 (5).
pp. 321-324.
ISSN 0936-6555
Full text not available from this repository.
Item Type: | Editorial |
---|---|
Authors (ICR Faculty only): | Johnston, Stephen and Bliss, Judith |
All Authors: | Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author] |
Uncontrolled Keywords: | 2 MULTICENTER TRIALS; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; TAMOXIFEN; ANASTROZOLE; DEPRIVATION; EXEMESTANE; CARCINOMA; SUPERIOR; CELLS |
Research teams: | Clinical Units > Breast Unit ICR divisions > Clinical Studies > Clinical Trials & Statistics Unit |
Depositing User: | Users 10 not found. |
Date Deposited: | 01 Jul 2008 08:52 |
Last Modified: | 10 Feb 2010 11:49 |
URI: | http://publications.icr.ac.uk/id/eprint/6483 |
Actions (login required)
![]() |
View Item |